ESR Test · Blood

If inflammation is building somewhere in your body, whether from an infection, an autoimmune condition, or the slow vascular damage that leads to heart disease, your ESR (erythrocyte sedimentation rate) will usually catch it. In a study following over 5,200 older adults for nearly 15 years, people with an ESR above 50 mm/h had roughly 89% higher risk of dying from any cause compared with those below 20 mm/h, even after accounting for age, weight, smoking, diabetes, and heart disease history.

ESR is one of the oldest and cheapest blood tests in medicine. It does not pinpoint a specific disease. Instead, it acts like a smoke detector: when the number rises, something inflammatory is happening, and your job is to find out what. That broad sensitivity is both its strength and its limitation.

What ESR Actually Measures

ESR is not a molecule. It is a physical measurement. A lab technician places your blood in a tall, narrow tube and waits one hour. The distance your red blood cells fall, measured in millimeters, is your ESR. When inflammation is present, the liver pumps out proteins called fibrinogen and immunoglobulins. These proteins coat your red blood cells and cause them to clump into stacks (a phenomenon called rouleaux formation), which makes them heavier and faster to sink.

Because ESR depends on these sticky proteins rather than on a single inflammatory signal, it reflects a broad mix of chronic and acute inflammation, immune activation, and even nutritional status. That is why it rises in so many different conditions and why it responds more slowly than other markers like CRP (C-reactive protein). CRP typically peaks within a day or two of an inflammatory trigger and falls quickly, while ESR may take two to three weeks to normalize.

Heart Disease and Cardiovascular Risk

The connection between chronic low-grade inflammation and heart disease is well established, and ESR captures it. In the Reykjavik Study, which tracked roughly 16,700 adults for about 20 years, men in the highest ESR group (10 mm/h or above) had about 57% higher risk of developing coronary heart disease compared with those in the lowest group (0 to 1 mm/h). Women showed a similar pattern, with about 49% higher risk in the top group (17 mm/h or above) versus the bottom (0 to 3 mm/h). These associations held steady after adjusting for cholesterol, blood pressure, BMI, and smoking.

A separate 15-year follow-up of the NHANES I cohort found that white men aged 45 to 64 in the highest ESR group had roughly 2.7 times the risk of dying from coronary heart disease compared with the lowest group. In a Swedish community study of middle-aged men, those in the top ESR quartile had about 46% higher risk of developing heart failure, independent of standard risk factors.

If your ESR is persistently in the upper range and you have no obvious inflammatory condition, it may be worth investigating cardiovascular risk more aggressively, including advanced lipid testing and coronary calcium scoring.

All-Cause Mortality

The Rotterdam Study provides the clearest population-level mortality data. Among 5,226 adults aged 55 and older, those with ESR between 20 and 50 mm/h had about 23% higher adjusted risk of dying from any cause, and those above 50 mm/h had about 89% higher risk, compared with the reference group below 20 mm/h. This held even in adults over 75 with no known chronic diseases: an ESR above 20 mm/h still predicted about 29% higher mortality. The authors specifically argue that elevated ESR in older adults should not be dismissed as a normal part of aging.

Infection

ESR is a standard part of infection workups, particularly for bone and joint infections. In a study of 265 children with culture-proven bone or joint infections, an ESR above 20 mm/h had 94% sensitivity for detecting infection. When ESR and CRP were combined, sensitivity reached 98 to 100%. If both markers stayed normal for three consecutive days, infection was essentially ruled out.

In diabetic foot infections, ESR helps stratify the likelihood of deeper bone involvement. An ESR below 30 mm/h makes osteomyelitis unlikely, while an ESR above 60 mm/h combined with elevated CRP strongly suggests it. However, severe kidney disease significantly reduces ESR's accuracy in this setting, dropping the diagnostic area under the curve from about 0.76 to 0.57.

Autoimmune and Rheumatic Disease

ESR is built into formal disease activity scores for rheumatoid arthritis (the DAS28-ESR score) and is routinely tracked in conditions like lupus, spondyloarthritis, and giant cell arteritis. In a large Japanese rheumatoid arthritis cohort of 4,555 patients, switching from ESR-based to CRP-based disease scoring actually underestimated disease activity, suggesting ESR captures dimensions of inflammation that CRP alone may miss.

That said, ESR is far from perfect in rheumatic disease. Many patients with active spondyloarthritis have a normal ESR, and newer blood-count-based ratios are increasingly used as complementary markers of disease activity.

Cancer

Markedly elevated ESR has long been associated with malignancy. In a classic series of 263 patients with ESR at or above 100 mm/h, malignancy was diagnosed in 58% of cases. ESR also carries prognostic weight in specific cancers: in early-stage Hodgkin lymphoma, patients whose ESR remained persistently elevated after treatment had roughly seven times the risk of death compared with those whose ESR normalized quickly. In a cohort of patients with inflammatory bowel disease, those in the highest quartile of time-averaged ESR had about twice the odds of developing colorectal cancer compared with the lowest quartile.

An Unexpected Finding: Parkinson's Disease

One of the largest ESR studies, following nearly 660,000 young Swedish men for up to 48 years, found that higher ESR in adolescence was actually associated with a modestly lower risk of later Parkinson's disease. For every doubling of ESR, the risk dropped by about 6%. This inverse relationship was approximately linear up to about 15 mm/h and then plateaued.

This does not mean inflammation protects the brain. Rather, it may reflect that very low inflammatory signaling in youth coincides with other biological traits that increase Parkinson's susceptibility decades later. The finding is a reminder that ESR is not a simple higher-is-worse marker in every context.

Reference Ranges

ESR is measured using the Westergren method (or a validated equivalent), reported in millimeters per hour (mm/h). Values vary by age and sex, and your lab's specific reference range should be your primary comparison point. The ranges below come from large population studies and give you an orientation framework.

In a study of 3,910 healthy Norwegian adults, about 76% had an ESR below 9 mm/h. The age- and sex-specific upper limits of normal (95th percentile) are shown below.

The "Optimal" column draws on the Reykjavik and Rotterdam cohort data, where the lowest ESR groups had the lowest cardiovascular and mortality risk. The "Moderately Elevated" and "Markedly Elevated" categories are from the Rotterdam Study, where each carried 23% and 89% higher adjusted mortality, respectively. Always compare your results within the same lab over time for the most meaningful trend.

When Results Can Be Misleading

ESR is influenced by many factors beyond active inflammation. Knowing what can push your number up or down without reflecting true disease will help you avoid overreacting to a single reading.

• Anemia: Low red blood cell count or low hemoglobin makes cells settle faster, artificially raising your ESR. If you are anemic, your ESR may look elevated even without significant inflammation.
• Low albumin: The protein albumin normally slows red cell sedimentation. Malnutrition, liver disease, or chronic illness that lowers albumin will push ESR up independently of inflammation. In one COPD study, anemia and low albumin were the strongest drivers of ESR, not lung disease severity.
• Age and sex: ESR rises naturally with age and is higher in women than in men at the same inflammatory load. A moderately elevated reading in an 80-year-old may carry a different meaning than the same number in a 30-year-old, though the Rotterdam Study argues it should still be investigated.
• Kidney disease: Chronic kidney disease raises ESR and also reduces its diagnostic accuracy. In patients with severe kidney impairment and diabetic foot infections, ESR's ability to diagnose bone infection dropped substantially.

Corticosteroids suppress ESR as part of their anti-inflammatory action. If you are taking prednisone or another steroid for any reason, a normal ESR does not rule out underlying inflammatory disease; the medication may be masking it. NSAIDs, when they trigger gastrointestinal inflammation or an IBD flare, can paradoxically raise ESR.

Why ESR and CRP Often Disagree

One of the most common interpretation mistakes is assuming ESR and CRP move together. In a study of 5,777 paired hospital tests, 33% of results were discordant. Twenty-eight percent showed high ESR with normal CRP, often explained by anemia, elevated immunoglobulins, or other non-inflammatory factors rather than active disease. Others had normal ESR with elevated CRP, reflecting genuine acute inflammation that ESR was too slow to catch.

This is why ordering both markers together and comparing them can be informative. A high ESR with normal CRP suggests a chronic or non-inflammatory cause (like low albumin or a paraprotein). A normal ESR with high CRP points to an acute process that ESR has not yet caught up with. Both elevated together is the strongest signal of active systemic inflammation.

Tracking Your Trend

A single ESR reading is a snapshot, and ESR is one of the most variable common blood tests. Its value comes from watching the trajectory over time. A rising trend from 5 to 15 to 25 mm/h over a year tells you far more than any single number, because it suggests an emerging inflammatory process before it crosses any formal threshold.

Get a baseline reading. If you are making lifestyle changes aimed at reducing inflammation (weight loss, dietary shifts, exercise), retest in 3 to 6 months. If your ESR is in the normal range and stable, annual monitoring is reasonable. If your ESR is above 20 mm/h with no obvious explanation, retest within 4 to 8 weeks to confirm it is persistent rather than a transient blip from a recent illness.

Because ESR responds slowly to changes (it takes roughly three weeks to normalize after an acute infection), it is better suited for tracking chronic inflammatory trends than for monitoring acute responses. CRP is the faster-reacting partner for day-to-day or week-to-week monitoring.

What to Do with an Abnormal Result

If your ESR comes back elevated, the next step depends on how high it is and what your other labs show.

• ESR mildly elevated (20 to 30 mm/h) with no symptoms: Retest in 4 to 8 weeks. Check a CRP alongside it. Review your hemoglobin, albumin, and kidney function, since all three can push ESR up without inflammation. If the repeat is normal, it was likely transient.
• ESR moderately elevated (30 to 50 mm/h) and persistent: Order CRP, a complete blood count (CBC) with differential, a comprehensive metabolic panel, and consider checking immunoglobulins and a urinalysis. If you have joint pain or stiffness, add rheumatoid factor and anti-CCP antibodies. This range warrants a clinical evaluation.
• ESR above 50 mm/h: This almost always has an identifiable cause. The most common categories are infection, autoimmune disease, malignancy, and kidney disease. A thorough workup is warranted, and involving a physician experienced in internal medicine or rheumatology is appropriate.
• ESR normal but CRP elevated: Do not be falsely reassured. Acute inflammation may be present but not yet reflected in your ESR. Follow the CRP.

From a prevention standpoint, a persistently elevated ESR, even in the 15 to 20 mm/h range, alongside other risk factors for cardiovascular disease should prompt you to consider advanced cardiac screening. The population data consistently show that lower ESR tracks with lower long-term risk.